CompletedNCT07561866

Impact of Diabetes, Short-term Weight Variability, Heart Failure Etiologies and Other Comorbidities on Survival in a National Telemonitored Heart Failure Cohort

Sponsor: Satelia

Trial Details

Condition	Chronic Heart Failure, Type 2 Diabetes, Diabetes (DM)
Intervention	Diabetes Status; Comorbidity Burden; Weight variability
Status	Completed
Participants	16,556
Est. Completion	3 Apr 2024
Last Updated	1 May 2026

Primary Outcome

Association Between Diabetes Status and All-Cause Mortality

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Age 18 years or older * Diagnosis of chronic heart failure * Enrolment in the national heart failure remote monitoring program between September 3, 2018, and April 3, 2024 * Availability of baseline clinical data including diabetes status Exclusion Criteria: * Missing baseline information on diabetes status * Missing follow-up data for survival status

Trial Sites

Countries

France

View Registry Entry

Related Analysis

French Telemonitoring Study Reveals Diabetes Impact on Heart Failure Survival — Insights for Australian Clinicians

Large French telemonitoring study of 16,556 heart failure patients reveals critical insights into diabetes impact on survival outcomes. Completed research provides evidence-based guidance for managing diabetic heart failure patients in contemporary clinical practice.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service